Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2001 Aug;85(2):149–154. doi: 10.1136/adc.85.2.149

Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial

J Ludvigsson 1, U Samuelsson 1, J Ernerudh 1, C Johansson 1, L Stenhammar 1, G Berlin 1
PMCID: PMC1718876  PMID: 11466190

Abstract

BACKGROUND—In recent years photopheresis, an extracorporeal form of photochemotherapy using psoralen and ultraviolet A irradiation of leucocytes, has been claimed to be an effective form of immunomodulation.
AIM—To evaluate its effect in type 1 diabetes we performed a double blind, controlled study using placebo tablets and sham pheresis in the control group.
METHODS—A total of 49 children, aged 10-18 years of age at diagnosis of type 1 diabetes were included; 40 fulfilled the study and were followed for three years (19 received active treatment with photopheresis and 21 placebo treatment).
RESULTS—The actively treated children secreted significantly more C peptide in urine during follow up than control children. C peptide values in serum showed corresponding differences between the two groups. The insulin dose/kg body weight needed to achieve satisfactory HbA1c values was always lower in the photopheresis group; there was no difference between the groups regarding HbA1c values during follow up. The treatment was well accepted except for nausea (n = 3) and urticaria (n = 1) in the actively treated group. There were no differences regarding weight or height, or episodes of infection between the two groups during follow up.
CONCLUSION—Photopheresis does have an effect in addition to its possible placebo effect, shown as a weak but significant effect on the disease process at the onset of type 1 diabetes, an effect still noted after three years of follow up.



Full Text

The Full Text of this article is available as a PDF (144.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assan R., Feutren G., Debray-Sachs M., Quiniou-Debrie M. C., Laborie C., Thomas G., Chatenoud L., Bach J. F. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus. Lancet. 1985 Jan 12;1(8420):67–71. doi: 10.1016/s0140-6736(85)91964-6. [DOI] [PubMed] [Google Scholar]
  2. Barr M. L., Meiser B. M., Eisen H. J., Roberts R. F., Livi U., Dall'Amico R., Dorent R., Rogers J. G., Radovancević B., Taylor D. O. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med. 1998 Dec 10;339(24):1744–1751. doi: 10.1056/NEJM199812103392404. [DOI] [PubMed] [Google Scholar]
  3. Berger C. L., Perez M., Laroche L., Edelson R. Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol. 1990 Jan;94(1):52–57. doi: 10.1111/1523-1747.ep12873349. [DOI] [PubMed] [Google Scholar]
  4. Bottazzo G. F., Florin-Christensen A., Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974 Nov 30;2(7892):1279–1283. doi: 10.1016/s0140-6736(74)90140-8. [DOI] [PubMed] [Google Scholar]
  5. Cadet J., Anselmino C., Douki T., Voituriez L. Photochemistry of nucleic acids in cells. J Photochem Photobiol B. 1992 Sep 15;15(4):277–298. doi: 10.1016/1011-1344(92)85135-h. [DOI] [PubMed] [Google Scholar]
  6. Costanzo-Nordin M. R., Hubbell E. A., O'Sullivan E. J., Johnson M. R., Mullen G. M., Heroux A. L., Kao W. G., McManus B. M., Pifarre R., Robinson J. A. Successful treatment of heart transplant rejection with photopheresis. Transplantation. 1992 Apr;53(4):808–815. doi: 10.1097/00007890-199204000-00021. [DOI] [PubMed] [Google Scholar]
  7. Coutant R., Landais P., Rosilio M., Johnsen C., Lahlou N., Chatelain P., Carel J. C., Ludvigsson J., Boitard C., Bougnères P. F. Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebo-controlled double blind trial. Diabetologia. 1998 Sep;41(9):1040–1046. doi: 10.1007/s001250051028. [DOI] [PubMed] [Google Scholar]
  8. Edelson R. L. Photopheresis. J Clin Apher. 1990;5(2):77–79. [PubMed] [Google Scholar]
  9. Edelson R., Berger C., Gasparro F., Jegasothy B., Heald P., Wintroub B., Vonderheid E., Knobler R., Wolff K., Plewig G. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med. 1987 Feb 5;316(6):297–303. doi: 10.1056/NEJM198702053160603. [DOI] [PubMed] [Google Scholar]
  10. Gasparro F. P., Dall'Amico R., Goldminz D., Simmons E., Weingold D. Molecular aspects of extracorporeal photochemotherapy. Yale J Biol Med. 1989 Nov-Dec;62(6):579–593. [PMC free article] [PubMed] [Google Scholar]
  11. Greinix H. T., Volc-Platzer B., Rabitsch W., Gmeinhart B., Guevara-Pineda C., Kalhs P., Krutmann J., Hönigsmann H., Ciovica M., Knobler R. M. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998 Nov 1;92(9):3098–3104. [PubMed] [Google Scholar]
  12. Grubin C. E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W. A., Li L., Karlsen A. E., Boel E., Michelsen B., Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 1994 Apr;37(4):344–350. doi: 10.1007/BF00408469. [DOI] [PubMed] [Google Scholar]
  13. Harrison L. C., Colman P. G., Dean B., Baxter R., Martin F. I. Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine. Diabetes. 1985 Dec;34(12):1306–1308. doi: 10.2337/diab.34.12.1306. [DOI] [PubMed] [Google Scholar]
  14. Heding L. G. Radioimmunological determination of human C-peptide in serum. Diabetologia. 1975 Dec;11(6):541–548. doi: 10.1007/BF01222104. [DOI] [PubMed] [Google Scholar]
  15. Kitagawa T., Ludvigsson J. Cyclosporine in diabetes mellitus. J Pediatr. 1988 Mar;112(3):500–501. doi: 10.1016/s0022-3476(88)80351-2. [DOI] [PubMed] [Google Scholar]
  16. Knobler R. M., Graninger W., Graninger W., Lindmaier A., Trautinger F., Smolen J. S. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. Arthritis Rheum. 1992 Mar;35(3):319–324. doi: 10.1002/art.1780350311. [DOI] [PubMed] [Google Scholar]
  17. Laroche L., Edelson R. L., Perez M., Berger C. L. Antigen-specific tolerance induced by autoimmunization with photoinactivated syngeneic effector cells. Ann N Y Acad Sci. 1991 Dec 30;636:113–123. doi: 10.1111/j.1749-6632.1991.tb33442.x. [DOI] [PubMed] [Google Scholar]
  18. Laskin J. D., Lee E., Yurkow E. J., Laskin D. L., Gallo M. A. A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA. Proc Natl Acad Sci U S A. 1985 Sep;82(18):6158–6162. doi: 10.1073/pnas.82.18.6158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ludvigsson J., Afoke A. O. Seasonality of type 1 (insulin-dependent) diabetes mellitus: values of C-peptide, insulin antibodies and haemoglobin A1c show evidence of a more rapid loss of insulin secretion in epidemic patients. Diabetologia. 1989 Feb;32(2):84–91. doi: 10.1007/BF00505179. [DOI] [PubMed] [Google Scholar]
  20. Ludvigsson J., Binder C., Mandrup-Poulsen T. Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children. Diabetologia. 1988 Sep;31(9):647–651. doi: 10.1007/BF00278746. [DOI] [PubMed] [Google Scholar]
  21. Ludvigsson J., Heding L. G. C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children. Acta Endocrinol (Copenh) 1977 Jun;85(2):364–371. doi: 10.1530/acta.0.0850364. [DOI] [PubMed] [Google Scholar]
  22. Ludvigsson J., Heding L., Liedén G., Marner B., Lernmark A. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. Br Med J (Clin Res Ed) 1983 Jan 15;286(6360):176–178. doi: 10.1136/bmj.286.6360.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ludvigsson J. Methodological aspects on C-peptide measurements. Acta Med Scand Suppl. 1983;671:53–59. doi: 10.1111/j.0954-6820.1983.tb08548.x. [DOI] [PubMed] [Google Scholar]
  24. Malawista S. E., Trock D. H., Edelson R. L. Treatment of rheumatoid arthritis by extracorporeal photochemotherapy. A pilot study. Arthritis Rheum. 1991 Jun;34(6):646–654. doi: 10.1002/art.1780340604. [DOI] [PubMed] [Google Scholar]
  25. Matthews J. N., Altman D. G., Campbell M. J., Royston P. Analysis of serial measurements in medical research. BMJ. 1990 Jan 27;300(6719):230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Panto F., Giordano C., Amato M. P., Pugliese A., Donatelli M., D'Acquisto G., Galluzzo A. The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patients. J Autoimmun. 1990 Oct;3(5):587–592. doi: 10.1016/s0896-8411(05)80025-3. [DOI] [PubMed] [Google Scholar]
  27. Parish N. M., Bowie L., Zusman Harach S., Phillips J. M., Cooke A. Thymus-dependent monoclonal antibody-induced protection from transferred diabetes. Eur J Immunol. 1998 Dec;28(12):4362–4373. doi: 10.1002/(SICI)1521-4141(199812)28:12<4362::AID-IMMU4362>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  28. Parrish J. A., Fitzpatrick T. B., Tanenbaum L., Pathak M. A. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974 Dec 5;291(23):1207–1211. doi: 10.1056/NEJM197412052912301. [DOI] [PubMed] [Google Scholar]
  29. Prinz B., Nachbar F., Plewig G. Treatment of severe atopic dermatitis with extracorporeal photopheresis. Arch Dermatol Res. 1994;287(1):48–52. doi: 10.1007/BF00370718. [DOI] [PubMed] [Google Scholar]
  30. Rook A. H., Freundlich B., Jegasothy B. V., Perez M. I., Barr W. G., Jimenez S. A., Rietschel R. L., Wintroub B., Kahaleh M. B., Varga J. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol. 1992 Mar;128(3):337–346. [PubMed] [Google Scholar]
  31. Rossetti F., Zulian F., Dall'Amico R., Messina C., Montini G., Zacchello F. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation. 1995 Jan 15;59(1):149–151. doi: 10.1097/00007890-199501150-00029. [DOI] [PubMed] [Google Scholar]
  32. Stiller C. R., Dupré J., Gent M., Jenner M. R., Keown P. A., Laupacis A., Martell R., Rodger N. W., von Graffenried B., Wolfe B. M. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science. 1984 Mar 30;223(4643):1362–1367. doi: 10.1126/science.6367043. [DOI] [PubMed] [Google Scholar]
  33. Vahlquist C., Larsson M., Ernerudh J., Berlin G., Skogh T., Vahlquist A. Treatment of psoriatic arthritis with extracorporeal photochemotherapy and conventional psoralen-ultraviolet A irradiation. Arthritis Rheum. 1996 Sep;39(9):1519–1523. doi: 10.1002/art.1780390911. [DOI] [PubMed] [Google Scholar]
  34. Wolfe J. T., Lessin S. R., Singh A. H., Rook A. H. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs. 1994 Dec;18(12):888–897. doi: 10.1111/j.1525-1594.1994.tb03340.x. [DOI] [PubMed] [Google Scholar]
  35. Yoo E. K., Rook A. H., Elenitsas R., Gasparro F. P., Vowels B. R. Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. J Invest Dermatol. 1996 Aug;107(2):235–242. doi: 10.1111/1523-1747.ep12329711. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES